APGE Q3 2025 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

APGEApogee Therapeutics, Inc.

$4B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$400,000

Operating Income

-$71M

Net Income

-$65M

EPS (Diluted)

$-1.11

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$54M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$626M

Total Liabilities

$40M

Stockholders' Equity

$586M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$400,000	$0	—
Operating Income	-$71M	-$59M	-21.5%
Net Income	-$65M	-$49M	-32.6%